WBA Q2 loss per share $6.85 on $5.8B VillageMD impairment; adj EPS $1.20, sales up 6.3%, guidance narrowed to $3.20-3.35

Walgreens Boots Alliance, Inc.

2024-Q2 EPS reported -$6.93 revenue$73,760,000,000

GAAP loss per share $6.85 vs EPS $0.81 YoY; includes $5.8B after-tax non-cash VillageMD goodwill impairment.
Adjusted EPS $1.20, up 3.4% (2.8% constant currency), on sales $37.1B (+6.3% YoY).
Fiscal 2024 adjusted EPS guidance narrowed to $3.20-3.35 from prior range; U.S. Healthcare achieved adjusted EBITDA profitability.
Actions: cost savings target $1B, strategic portfolio review over next 3 months, early wind-down of sale-leaseback program.
Cencora share sales and challenging retail environment cited as headwinds; lower adjusted effective tax rate provides offset.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Walgreens Boots Alliance, Inc. reported the fiscal quarter ended February 29, 2024 results: revenue $37.1 billion, EPS $6.85. Guidance reaffirmed.

Period: the fiscal quarter ended February 29, 2024
Revenue: $37.1 billion
EPS: $6.85
Guidance: reaffirmed
Result: reported results

Exact text from the filing

basis reflecting lower adjusted effective tax rate** and improved profitability in U.S. Healthcare • Second quarter sales increased 6.3 percent year-over-year to $37.1 billion, up 5.7 percent on a constant currency basis Fiscal 2024 guidance 1 • Narrowing fiscal 2024 adjusted EPS** guidance to $3.20 to $3.35, reflecting challenging retail environment

View on SEC.gov

326 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001193125-24-079608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.